Company Name:AC Immune SA
CEO: Andrea Pfeifer

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: AC Immune SA is a clinical stage biopharmaceutical company. It discovers, designs and develops novel, proprietary medicines for treatment of neurodegenerative diseases with the help of proprietary platforms.


Key numbers

Market Capitalization:621573160
Shares Outstanding: 67562300
Float: 33326253
Next Earning Date:2020-03-18
TTm EPS: 0.7397
TTm Dividend Rate:
200 days moving average:5.94
50 days moving average: 8.1
One day percent Change: -5.25



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,